Cargando…
The screening of diagnostic biomarker microRNA in first-trimester maternal plasma for Down syndrome: A study protocol
BACKGROUND: The trisomy of human chromosome 21 causes Down syndrome (DS), sometimes known as congenital folly's syndrome. The survivors show apparent mental impairment, unusual facial traits, growth and development abnormalities, and various deformities, with 60 percent of the infants having mi...
Autores principales: | He, Fengping, Yang, Xiangkang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772682/ https://www.ncbi.nlm.nih.gov/pubmed/35060501 http://dx.doi.org/10.1097/MD.0000000000028495 |
Ejemplares similares
-
Identification of microRNAs as diagnostic biomarkers for acute myocardial infarction in Asian populations: A systematic review and meta-analysis
por: Wang, Qian, et al.
Publicado: (2017) -
Circulating microRNAs as biomarkers for severe coronary artery disease
por: Zhang, Xuelin, et al.
Publicado: (2020) -
Differential Expression of Hypertension-Associated MicroRNAs in the Plasma of Patients With White Coat Hypertension
por: Cengiz, Mahir, et al.
Publicado: (2015) -
The clinical value of color ultrasound screening for fetal cardiovascular abnormalities during the second trimester: A systematic review and meta-analysis
por: Shi, Bingye, et al.
Publicado: (2023) -
Clinical analysis of prenatal ultrasound diagnosis of fetal cardiovascular malformations in the first and second trimesters of pregnancy: A CARE-compliant article
por: Han, Bing, et al.
Publicado: (2019)